Your browser doesn't support javascript.
loading
The 5th Kidney Cancer Research Summit: Research Accelerating Cures for Renal Cell Carcinoma in 2023.
Choueiri, Toni K; Pal, Sumanta K; Lewis, Bryan; Poteat, Susan; Pels, Kevin; Hammers, Hans.
Afiliação
  • Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Pal SK; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Lewis B; KidneyCAN, Philadelphia, PA, USA.
  • Poteat S; KidneyCAN, Philadelphia, PA, USA.
  • Pels K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hammers H; Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Oncologist ; 29(2): 91-98, 2024 Feb 02.
Article em En | MEDLINE | ID: mdl-38048064
The 5th Kidney Cancer Research Summit was a hybrid event hosted in Boston, MA in July 2023. As in previous editions, the conference attracted a wide representation of global thought leaders in kidney cancer spanning all stages of clinical and laboratory research. Sessions covered tumor metabolism, novel immune pathways, advances in clinical trials and immunotherapy, and progress toward biomarkers. The abstract presentations were published as a supplement in The Oncologist (https://academic.oup.com/oncolo/issue/28/Supplement_1). Aiming to be more concise than comprehensive, this commentary summarizes the most important emerging areas of kidney cancer research discussed and debated among the stakeholders at the conference, with relevant updates that have occurred since.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article